Project Grant H23IP322561

This federal Project Grant award of $220,000.00 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop and test a novel intervention to improve routine vaccination of hospitalized children. The project, titled "PRESUMPTIVELY INITIATING VACCINES AND OPTIMIZING TALK FOR INPATIENTS (PIVOT-IN)", will involve two key components: 1) a standardized screening approach to...

This federal Cooperative Agreement award, with a total funding amount of $3,047,740.00, was provided by the National Center for Immunization and Respiratory Diseases, a division of the Centers for Disease Control and Prevention (CDC). The award supports the "Partnerships to Enhance Immunization Information Systems" project under the CDC's Federal Grant Program CFDA 93.185 "Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills...

This $820,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) is intended to strengthen routine immunization and vaccine equity in the Democratic Republic of the Congo and Brazil. The prime awardee, World Vision Inc., is a global non-profit organization that specializes in delivering humanitarian aid, emergency relief, and development services worldwide. Through this 5-year award, which runs...

This Project Grant award from the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $2,146,691 to study the effects of the RSV prefusion F protein-based (RSVpref) vaccine on neonatal, lactation, and child health outcomes. The study will analyze data from up to 20,000 mother-infant dyads across four large health systems in Hawaii, Oregon, Washington, Minnesota, and Wisconsin, using electronic...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $950,092 to Seattle Children's Hospital (dba Seattle Children's Research Institute) to develop targeted vaccine candidates against nontuberculous mycobacterial (NTM) infections. The research aims to create an adjuvanted subunit vaccine and a novel replicon RNA-based vaccine to improve immunity and prevent NTM...

This $793,102 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to investigate the interplay between maternal antibodies and newborn vaccine responses to influenza virus. The primary goal is to effectively vaccinate young infants when maternal antibody levels are high, such that as maternal antibody wanes, a protective anti-influenza response is rising in the infant. The...

This $209,750 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will leverage antibody-based approaches to prevent and detect tuberculosis (TB) in children affected by HIV. The key goals are to: 1) Define antibody Fc features associated with protection from Mycobacterium tuberculosis (MTB) infection in infants with and without maternal HIV exposure, and 2) Identify biomarkers for...

This federal Cooperative Agreement award in the amount of $1,050,000.00 was issued on September 30, 2024 by the National Center for Immunization and Respiratory Diseases, part of the Centers for Disease Control and Prevention (CDC). The award is funded under the CDC's Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program, which aims to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases. The award will...

The federal Project Grant award R21AI191038, totaling $249,276.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to evaluate the real-world effectiveness of maternal respiratory syncytial virus (RSV) vaccination. RSV is a leading cause of lower respiratory tract infections in infants, contributing to millions of cases and tens of thousands of deaths...

This federal block grant award of $3,147,408.00, provided by the Center for Medicaid and CHIP Services on October 1, 2023, supports the Virgin Islands Department of Health Group's Federal Grants Coordination & Monitoring Division in administering the Children's Health Insurance Program (CHIP, CFDA 93.767) in the U.S. Virgin Islands. The funding will enable the division to maintain and expand health insurance coverage and access to healthcare services for uninsured, low-income children, and...